HopeStage
Back to all studies
CompletedNCT02489305

Measures That May Predict Relapse in Major Depression

About this titleRead the official source — NCT02489305
Observational studyAges 18–64United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 64 years.

Listed locations
Birmingham and 24 more locationsSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: December 15, 2014
Recruitment status
Completed
Enrollment listed in the registry
330
Sponsor
Janssen Research & Development, LLC
Sponsor type
Other organization
Study type
Observational
Intervention type
Interview / survey / observational
Locations
United States
Age range
From 18 Years to 64 Years
Official registry ID
NCT02489305
Official title
Show the full official title

A Prospective, Longitudinal, Observational Study to Evaluate Potential Predictors of Relapse in Subjects With Major Depressive Disorder Who Have Responded to Antidepressant Treatment

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Birmingham · Glendale · Oceanside

22 more locations
  • San Diego
  • Sherman Oaks
  • Stanford
  • Hartford
  • Jacksonville
  • Orlando
  • Tampa
  • Augusta
  • Chicago
  • Skokie
  • Springfield
  • Iowa City
  • Wichita
  • Worcester
  • Ann Arbor
  • Durham
  • Cincinnati
  • Philadelphia
  • Charleston
  • Dallas
  • Houston
  • Salt Lake City

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Janssen Research & Development, LLC.

Who was this study for?

Listed age limits: 18 years to 64 years.

Want to explore more studies?

Explore studies